{"abstracts-retrieval-response": {
    "item": {
        "ait:process-info": {
            "ait:status": {
                "@state": "update",
                "@type": "core",
                "@stage": "S300"
            },
            "ait:date-delivered": {
                "@day": "07",
                "@timestamp": "2021-11-07T01:24:19.000019-04:00",
                "@year": "2021",
                "@month": "11"
            },
            "ait:date-sort": {
                "@day": "01",
                "@year": "2019",
                "@month": "08"
            }
        },
        "xocs:meta": {"xocs:funding-list": {
            "@pui-match": "primary",
            "@has-funding-info": "1",
            "xocs:funding": {
                "xocs:funding-agency-matched-string": "Chulalongkorn University",
                "xocs:funding-agency-acronym": "CU",
                "xocs:funding-agency": "Chulalongkorn University",
                "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/501100002873",
                "xocs:funding-agency-country": "http://sws.geonames.org/1605651/"
            },
            "xocs:funding-addon-generated-timestamp": "2021-06-03T20:19:40.608Z",
            "xocs:funding-text": "The present trial was performed with the support of the Division of Cardiology, Department of Medicine. Faculty of Medicine, Chulalongkorn University.",
            "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"
        }},
        "bibrecord": {
            "head": {
                "author-group": {
                    "affiliation": {
                        "country": "Thailand",
                        "@afid": "60028190",
                        "@country": "tha",
                        "city": "Bangkok",
                        "organization": [
                            {"$": "Division of Cardiology"},
                            {"$": "Department of Medicine"},
                            {"$": "Faculty of Medicine"},
                            {"$": "Chulalongkorn University"}
                        ],
                        "affiliation-id": {
                            "@afid": "60028190",
                            "@dptid": "113019942"
                        },
                        "ce:source-text": "Division of Cardiology, Department of Medicine., Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand",
                        "@dptid": "113019942"
                    },
                    "author": [
                        {
                            "preferred-name": {
                                "ce:given-name": "R.",
                                "ce:initials": "R.",
                                "ce:surname": "Kaewkanlaya",
                                "ce:indexed-name": "Kaewkanlaya R."
                            },
                            "@seq": "1",
                            "ce:initials": "R.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD.",
                            "ce:surname": "Kaewkanlaya",
                            "@auid": "57210963784",
                            "ce:indexed-name": "Kaewkanlaya R."
                        },
                        {
                            "preferred-name": {
                                "ce:given-name": "R.",
                                "ce:initials": "R.",
                                "ce:surname": "Chokesuwattanaskul",
                                "ce:indexed-name": "Chokesuwattanaskul R."
                            },
                            "@seq": "2",
                            "ce:initials": "R.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD.",
                            "ce:surname": "Chokesuwattanaskul",
                            "@auid": "57202543782",
                            "ce:indexed-name": "Chokesuwattanaskul R."
                        },
                        {
                            "preferred-name": {
                                "ce:given-name": "S.",
                                "ce:initials": "S.",
                                "ce:surname": "Sb. Songmuang",
                                "ce:indexed-name": "Sb. Songmuang S."
                            },
                            "@seq": "3",
                            "ce:initials": "S.",
                            "@_fa": "true",
                            "@type": "auth",
                            "ce:degrees": "MD.",
                            "ce:surname": "Sb. Songmuang",
                            "@auid": "57210957387",
                            "ce:indexed-name": "Sb. Songmuang S."
                        }
                    ]
                },
                "citation-title": "Optimal INR to prevent stroke in thai patients with rheumatic mitral stenosis and atrial fibrillation who are receiving warfarin",
                "abstracts": "© JOURNAL OF THE MEDICAL ASSOCIATION OF THAILAND.Objective: To determine the optimal international normalized ratio (INR) level to prevent stroke and bleeding in patients with rheumatic mitral stenosis and atrial fibrillation (AF) receiving warfarin. Materials and Methods: The present study was a retrospective study that enrolled patients with rheumatic mitral stenosis and AF who received warfarin at King Chulalongkorn Memorial Hospital between January 1, 2010 and December 31, 2015. The INR range was classified into six groups, which were less than 1.50, 1.50 to 1.99, 2.00 to 2.49, 2.50 to 2.99, 3.00 to 3.49 and 3.50 and more. Results: One hundred eighty-four patients (mean age of 55.7 years, 79.3% female) were enrolled, for a follow-up of 714.4 patient- year. Twenty-eight patients had 35 ischemic stroke events (4.90 per 100 patient-years) and 36 patients had 55 bleeding events (7.70 per 100 patient-years). The time rate in the INR range of less than 1.50, 1.50 to 1.99, 2.00 to 2.49, 2.50 to 2.99, 3.00 to 3.49 and 3.50 and more were 14.0%, 26.7%, 29.5%, 17.4%, 7.1%, and 5.2%, respectively. The percentage of patient-time spent within INR range 2 to 3, INR less than 2, and INR more than 3 were 46.9%, 40.7%, and 12.3%, respectively. The INR level less than 2.00 increased the incidence rate of ischemic stroke (relative risk [RR] 1.57; 95% confidence interval [CI] 1.19 to 2.13; p=0.028). The INR level more than 2.99 to 3.5 increased the incidence rate of total and major bleeding events (RR 2.47; 95% CI 1.88 to 3.23; p<0.001 and RR 3.07; 95% CI 2.44 to 3.87; p<0.001, respectively). The overall of ischemic stroke and bleeding event rate was lowest in the INR range from 2.00 to 2.99. Conclusion: In this large cohort of patients with rheumatic mitral stenosis and AF, an INR level between 2.00 to 2.99 was associated with the lowest incidence of ischemic stroke and bleeding. This optimal INR level is higher than the optimal INR as previously shown in other studies of Asian patients with non-valvular AF.",
                "correspondence": {
                    "affiliation": {
                        "country": "Thailand",
                        "address-part": "Rama IV Road Pathumwan",
                        "postal-code": "10330",
                        "@country": "tha",
                        "city": "Bangkok",
                        "organization": [
                            {"$": "Division of Cardiology"},
                            {"$": "Department of Medicine"},
                            {"$": "Faculty of Medicine"},
                            {"$": "Chulalongkorn University"}
                        ],
                        "ce:source-text": "Division of Cardiology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Rama IV Road, Pathumwan, Bangkok, 10330, Thailand"
                    },
                    "person": {
                        "ce:initials": "R.",
                        "ce:degrees": "MD.",
                        "ce:surname": "Kaewkanlaya",
                        "ce:indexed-name": "Kaewkanlaya R."
                    }
                },
                "citation-info": {
                    "author-keywords": {"author-keyword": [
                        {
                            "$": "Atrial fibrillation",
                            "@xml:lang": "eng"
                        },
                        {
                            "$": "INR",
                            "@xml:lang": "eng"
                        },
                        {
                            "$": "Rheumatic mitral stenosis",
                            "@xml:lang": "eng"
                        },
                        {
                            "$": "Stroke",
                            "@xml:lang": "eng"
                        },
                        {
                            "$": "Warfarin",
                            "@xml:lang": "eng"
                        }
                    ]},
                    "citation-type": {"@code": "ar"},
                    "citation-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    },
                    "abstract-language": {
                        "@language": "English",
                        "@xml:lang": "eng"
                    }
                },
                "source": {
                    "website": {"ce:e-address": {
                        "$": "http://www.jmatonline.com/index.php/jmat/article/viewfile/7988/8711",
                        "@type": "email"
                    }},
                    "translated-sourcetitle": {
                        "$": "Journal of the Medical Association of Thailand",
                        "@xml:lang": "eng"
                    },
                    "volisspag": {
                        "voliss": {
                            "@volume": "102",
                            "@issue": "8"
                        },
                        "pagerange": {
                            "@first": "904",
                            "@last": "910"
                        }
                    },
                    "@type": "j",
                    "sourcetitle": "Journal of the Medical Association of Thailand",
                    "publicationdate": {
                        "month": "08",
                        "year": "2019",
                        "date-text": "August 2019",
                        "day": "01"
                    },
                    "codencode": "JMTHB",
                    "sourcetitle-abbrev": "J. Med. Assoc. Thailand",
                    "@country": "tha",
                    "issn": {
                        "$": "01252208",
                        "@type": "print"
                    },
                    "publicationyear": {"@first": "2019"},
                    "publisher": {
                        "publishername": "Medical Association of Thailand",
                        "ce:e-address": {
                            "$": "math@loxinfo.co.th",
                            "@type": "email"
                        }
                    },
                    "@srcid": "17780"
                },
                "enhancement": {
                    "classificationgroup": {"classifications": [
                        {
                            "@type": "EMCLASS",
                            "classification": [
                                {
                                    "classification-code": "18",
                                    "classification-description": "Cardiovascular Diseases and Cardiovascular Surgery"
                                },
                                {
                                    "classification-code": "37",
                                    "classification-description": "Drug Literature Index"
                                },
                                {
                                    "classification-code": "8",
                                    "classification-description": "Neurology and Neurosurgery"
                                }
                            ]
                        },
                        {
                            "@type": "ASJC",
                            "classification": "2700"
                        },
                        {
                            "@type": "SUBJABBR",
                            "classification": "MEDI"
                        }
                    ]},
                    "chemicalgroup": {"chemicals": {
                        "@source": "esbd",
                        "chemical": [
                            {
                                "cas-registry-number": [
                                    {"$": "493-53-8"},
                                    {"$": "50-78-2"},
                                    {"$": "53663-74-4"},
                                    {"$": "53664-49-6"},
                                    {"$": "63781-77-1"}
                                ],
                                "chemical-name": "acetylsalicylic acid"
                            },
                            {
                                "cas-registry-number": [
                                    {"$": "113665-84-2"},
                                    {"$": "120202-66-6"},
                                    {"$": "90055-48-4"},
                                    {"$": "94188-84-8"}
                                ],
                                "chemical-name": "clopidogrel"
                            },
                            {
                                "cas-registry-number": [
                                    {"$": "129-06-6"},
                                    {"$": "2610-86-8"},
                                    {"$": "3324-63-8"},
                                    {"$": "5543-58-8"},
                                    {"$": "81-81-2"}
                                ],
                                "chemical-name": "warfarin"
                            }
                        ]
                    }}
                },
                "grantlist": {
                    "@complete": "y",
                    "grant-text": {
                        "$": "The present trial was performed with the support of the Division of Cardiology, Department of Medicine. Faculty of Medicine, Chulalongkorn University.",
                        "@xml:lang": "eng"
                    }
                }
            },
            "item-info": {
                "copyright": {
                    "$": "Copyright 2019 Elsevier B.V., All rights reserved.",
                    "@type": "Elsevier"
                },
                "dbcollection": [
                    {"$": "EMBASE"},
                    {"$": "REAXYSCAR"},
                    {"$": "SCOPUS"},
                    {"$": "Scopusbase"}
                ],
                "history": {"date-created": {
                    "@day": "02",
                    "@timestamp": "BST 10:11:54",
                    "@year": "2019",
                    "@month": "10"
                }},
                "itemidlist": {"itemid": [
                    {
                        "$": "2002507266",
                        "@idtype": "PUI"
                    },
                    {
                        "$": "920248034",
                        "@idtype": "CAR-ID"
                    },
                    {
                        "$": "20190660309",
                        "@idtype": "EMBASE"
                    },
                    {
                        "$": "20191783852",
                        "@idtype": "REAXYSCAR"
                    },
                    {
                        "$": "20192616336",
                        "@idtype": "SCOPUS"
                    },
                    {
                        "$": "20190009315928",
                        "@idtype": "TPA-ID"
                    },
                    {
                        "$": "85072010649",
                        "@idtype": "SCP"
                    },
                    {
                        "$": "85072010649",
                        "@idtype": "SGR"
                    }
                ]}
            },
            "tail": {"bibliography": {
                "@refcount": "7",
                "reference": [
                    {
                        "ref-fulltext": "Hylek EM, Skates SJ, Sheehan MA, Singer DE. An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation. N Engl J Med 1996;335:540-6.",
                        "@id": "1",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1996"},
                            "ref-title": {"ref-titletext": "An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0029741822",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "335"},
                                "pagerange": {
                                    "@first": "540",
                                    "@last": "546"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "E.M.",
                                    "@_fa": "true",
                                    "ce:surname": "Hylek",
                                    "ce:indexed-name": "Hylek E.M."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "S.J.",
                                    "@_fa": "true",
                                    "ce:surname": "Skates",
                                    "ce:indexed-name": "Skates S.J."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "M.A.",
                                    "@_fa": "true",
                                    "ce:surname": "Sheehan",
                                    "ce:indexed-name": "Sheehan M.A."
                                },
                                {
                                    "@seq": "4",
                                    "ce:initials": "D.E.",
                                    "@_fa": "true",
                                    "ce:surname": "Singer",
                                    "ce:indexed-name": "Singer D.E."
                                }
                            ]},
                            "ref-sourcetitle": "N Engl J Med"
                        },
                        "ce:source-text": "Hylek EM, Skates SJ, Sheehan MA, Singer DE. An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation. N Engl J Med 1996;335:540-6."
                    },
                    {
                        "ref-fulltext": "Methavigul K, Boonyapisit W. Optimal INR level in Thai atrial fibrillation patients who were receiving warfarin for stroke prevention in Thailand. J Med Assoc Thai 2014;97:1274-80.",
                        "@id": "2",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "Optimal INR level in Thai atrial fibrillation patients who were receiving warfarin for stroke prevention in Thailand"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84924338999",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "97"},
                                "pagerange": {
                                    "@first": "1274",
                                    "@last": "1280"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "K.",
                                    "@_fa": "true",
                                    "ce:surname": "Methavigul",
                                    "ce:indexed-name": "Methavigul K."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "W.",
                                    "@_fa": "true",
                                    "ce:surname": "Boonyapisit",
                                    "ce:indexed-name": "Boonyapisit W."
                                }
                            ]},
                            "ref-sourcetitle": "J Med Assoc Thai"
                        },
                        "ce:source-text": "Methavigul K, Boonyapisit W. Optimal INR level in Thai atrial fibrillation patients who were receiving warfarin for stroke prevention in Thailand. J Med Assoc Thai 2014;97:1274-80."
                    },
                    {
                        "ref-fulltext": "Cheung CM, Tsoi TH, Huang CY. The lowest effective intensity of prophylactic anticoagulation for patients with atrial fibrillation. Cerebrovasc Dis 2005;20:114-9.",
                        "@id": "3",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2005"},
                            "ref-title": {"ref-titletext": "The lowest effective intensity of prophylactic anticoagulation for patients with atrial fibrillation"},
                            "refd-itemidlist": {"itemid": {
                                "$": "23844479021",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "20"},
                                "pagerange": {
                                    "@first": "114",
                                    "@last": "119"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "C.M.",
                                    "@_fa": "true",
                                    "ce:surname": "Cheung",
                                    "ce:indexed-name": "Cheung C.M."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "T.H.",
                                    "@_fa": "true",
                                    "ce:surname": "Tsoi",
                                    "ce:indexed-name": "Tsoi T.H."
                                },
                                {
                                    "@seq": "3",
                                    "ce:initials": "C.Y.",
                                    "@_fa": "true",
                                    "ce:surname": "Huang",
                                    "ce:indexed-name": "Huang C.Y."
                                }
                            ]},
                            "ref-sourcetitle": "Cerebrovasc Dis"
                        },
                        "ce:source-text": "Cheung CM, Tsoi TH, Huang CY. The lowest effective intensity of prophylactic anticoagulation for patients with atrial fibrillation. Cerebrovasc Dis 2005;20:114-9."
                    },
                    {
                        "ref-fulltext": "Darby AE, Dimarco JP. Management of atrial fibrillation in patients with structural heart disease. Circulation 2012;125:945-57.",
                        "@id": "4",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2012"},
                            "ref-title": {"ref-titletext": "Management of atrial fibrillation in patients with structural heart disease"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84857574968",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "125"},
                                "pagerange": {
                                    "@first": "945",
                                    "@last": "957"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "A.E.",
                                    "@_fa": "true",
                                    "ce:surname": "Darby",
                                    "ce:indexed-name": "Darby A.E."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "J.P.",
                                    "@_fa": "true",
                                    "ce:surname": "Dimarco",
                                    "ce:indexed-name": "Dimarco J.P."
                                }
                            ]},
                            "ref-sourcetitle": "Circulation"
                        },
                        "ce:source-text": "Darby AE, Dimarco JP. Management of atrial fibrillation in patients with structural heart disease. Circulation 2012;125:945-57."
                    },
                    {
                        "ref-fulltext": "De Caterina R, Camm AJ. What is \u2018valvular\u2019 atrial fibrillation? A reappraisal. Eur Heart J 2014;35:3328-35.",
                        "@id": "5",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2014"},
                            "ref-title": {"ref-titletext": "What is \u2018valvular\u2019 atrial fibrillation? A reappraisal"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84925624084",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "35"},
                                "pagerange": {
                                    "@first": "3328",
                                    "@last": "3335"
                                }
                            },
                            "ref-authors": {"author": [
                                {
                                    "@seq": "1",
                                    "ce:initials": "R.",
                                    "@_fa": "true",
                                    "ce:surname": "De Caterina",
                                    "ce:indexed-name": "De Caterina R."
                                },
                                {
                                    "@seq": "2",
                                    "ce:initials": "A.J.",
                                    "@_fa": "true",
                                    "ce:surname": "Camm",
                                    "ce:indexed-name": "Camm A.J."
                                }
                            ]},
                            "ref-sourcetitle": "Eur Heart J"
                        },
                        "ce:source-text": "De Caterina R, Camm AJ. What is \u2018valvular\u2019 atrial fibrillation? A reappraisal. Eur Heart J 2014;35:3328-35."
                    },
                    {
                        "ref-fulltext": "Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 2016;37:2893-962.",
                        "@id": "6",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "2016"},
                            "ref-title": {"ref-titletext": "ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS"},
                            "refd-itemidlist": {"itemid": {
                                "$": "84994501747",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {
                                    "@volume": "2016",
                                    "@issue": "37"
                                },
                                "pagerange": {
                                    "@first": "2893",
                                    "@last": "2962"
                                }
                            },
                            "ref-authors": {
                                "author": [
                                    {
                                        "@seq": "1",
                                        "ce:initials": "P.",
                                        "@_fa": "true",
                                        "ce:surname": "Kirchhof",
                                        "ce:indexed-name": "Kirchhof P."
                                    },
                                    {
                                        "@seq": "2",
                                        "ce:initials": "S.",
                                        "@_fa": "true",
                                        "ce:surname": "Benussi",
                                        "ce:indexed-name": "Benussi S."
                                    },
                                    {
                                        "@seq": "3",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Kotecha",
                                        "ce:indexed-name": "Kotecha D."
                                    },
                                    {
                                        "@seq": "4",
                                        "ce:initials": "A.",
                                        "@_fa": "true",
                                        "ce:surname": "Ahlsson",
                                        "ce:indexed-name": "Ahlsson A."
                                    },
                                    {
                                        "@seq": "5",
                                        "ce:initials": "D.",
                                        "@_fa": "true",
                                        "ce:surname": "Atar",
                                        "ce:indexed-name": "Atar D."
                                    },
                                    {
                                        "@seq": "6",
                                        "ce:initials": "B.",
                                        "@_fa": "true",
                                        "ce:surname": "Casadei",
                                        "ce:indexed-name": "Casadei B."
                                    }
                                ],
                                "et-al": null
                            },
                            "ref-sourcetitle": "Eur Heart J"
                        },
                        "ce:source-text": "Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 2016;37:2893-962."
                    },
                    {
                        "ref-fulltext": "Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. EAFT (EuropeanAtrial Fibrillation Trial) Study Group. Lancet 1993;342:1255-62",
                        "@id": "7",
                        "ref-info": {
                            "ref-publicationyear": {"@first": "1993"},
                            "refd-itemidlist": {"itemid": {
                                "$": "0027505093",
                                "@idtype": "SGR"
                            }},
                            "ref-volisspag": {
                                "voliss": {"@volume": "342"},
                                "pagerange": {
                                    "@first": "1255",
                                    "@last": "1262"
                                }
                            },
                            "ref-text": "EAFT (EuropeanAtrial Fibrillation Trial) Study Group. Lancet",
                            "ref-sourcetitle": "Secondary Prevention in Non-Rheumatic Atrial Fibrillation after Transient Ischaemic Attack Or Minor Stroke"
                        },
                        "ce:source-text": "Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. EAFT (EuropeanAtrial Fibrillation Trial) Study Group. Lancet 1993;342:1255-62"
                    }
                ]
            }}
        }
    },
    "affiliation": {
        "affiliation-city": "Bangkok",
        "@id": "60028190",
        "affilname": "Chulalongkorn University",
        "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
        "affiliation-country": "Thailand"
    },
    "coredata": {
        "srctype": "j",
        "eid": "2-s2.0-85072010649",
        "dc:description": "Objective: To determine the optimal international normalized ratio (INR) level to prevent stroke and bleeding in patients with rheumatic mitral stenosis and atrial fibrillation (AF) receiving warfarin. Materials and Methods: The present study was a retrospective study that enrolled patients with rheumatic mitral stenosis and AF who received warfarin at King Chulalongkorn Memorial Hospital between January 1, 2010 and December 31, 2015. The INR range was classified into six groups, which were less than 1.50, 1.50 to 1.99, 2.00 to 2.49, 2.50 to 2.99, 3.00 to 3.49 and 3.50 and more. Results: One hundred eighty-four patients (mean age of 55.7 years, 79.3% female) were enrolled, for a follow-up of 714.4 patient- year. Twenty-eight patients had 35 ischemic stroke events (4.90 per 100 patient-years) and 36 patients had 55 bleeding events (7.70 per 100 patient-years). The time rate in the INR range of less than 1.50, 1.50 to 1.99, 2.00 to 2.49, 2.50 to 2.99, 3.00 to 3.49 and 3.50 and more were 14.0%, 26.7%, 29.5%, 17.4%, 7.1%, and 5.2%, respectively. The percentage of patient-time spent within INR range 2 to 3, INR less than 2, and INR more than 3 were 46.9%, 40.7%, and 12.3%, respectively. The INR level less than 2.00 increased the incidence rate of ischemic stroke (relative risk [RR] 1.57; 95% confidence interval [CI] 1.19 to 2.13; p=0.028). The INR level more than 2.99 to 3.5 increased the incidence rate of total and major bleeding events (RR 2.47; 95% CI 1.88 to 3.23; p<0.001 and RR 3.07; 95% CI 2.44 to 3.87; p<0.001, respectively). The overall of ischemic stroke and bleeding event rate was lowest in the INR range from 2.00 to 2.99. Conclusion: In this large cohort of patients with rheumatic mitral stenosis and AF, an INR level between 2.00 to 2.99 was associated with the lowest incidence of ischemic stroke and bleeding. This optimal INR level is higher than the optimal INR as previously shown in other studies of Asian patients with non-valvular AF.",
        "prism:coverDate": "2019-08-01",
        "prism:aggregationType": "Journal",
        "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85072010649",
        "dc:creator": {"author": [{
            "preferred-name": {
                "ce:given-name": "R.",
                "ce:initials": "R.",
                "ce:surname": "Kaewkanlaya",
                "ce:indexed-name": "Kaewkanlaya R."
            },
            "@seq": "1",
            "ce:initials": "R.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:degrees": "MD.",
            "ce:surname": "Kaewkanlaya",
            "@auid": "57210963784",
            "author-url": "https://api.elsevier.com/content/author/author_id/57210963784",
            "ce:indexed-name": "Kaewkanlaya R."
        }]},
        "link": [
            {
                "@_fa": "true",
                "@rel": "self",
                "@href": "https://api.elsevier.com/content/abstract/scopus_id/85072010649"
            },
            {
                "@_fa": "true",
                "@rel": "scopus",
                "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85072010649&origin=inward"
            },
            {
                "@_fa": "true",
                "@rel": "scopus-citedby",
                "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85072010649&origin=inward"
            }
        ],
        "source-id": "17780",
        "citedby-count": "0",
        "prism:volume": "102",
        "subtype": "ar",
        "dc:title": "Optimal INR to prevent stroke in thai patients with rheumatic mitral stenosis and atrial fibrillation who are receiving warfarin",
        "openaccess": null,
        "prism:issn": "01252208",
        "publishercopyright": "© JOURNAL OF THE MEDICAL ASSOCIATION OF THAILAND.",
        "prism:issueIdentifier": "8",
        "subtypeDescription": "Article",
        "prism:publicationName": "Journal of the Medical Association of Thailand",
        "prism:pageRange": "904-910",
        "prism:endingPage": "910",
        "openaccessFlag": null,
        "prism:startingPage": "904",
        "dc:identifier": "SCOPUS_ID:85072010649",
        "dc:publisher": "Medical Association of Thailandmath@loxinfo.co.th"
    },
    "idxterms": null,
    "language": {"@xml:lang": "eng"},
    "authkeywords": {"author-keyword": [
        {
            "@_fa": "true",
            "$": "Atrial fibrillation"
        },
        {
            "@_fa": "true",
            "$": "INR"
        },
        {
            "@_fa": "true",
            "$": "Rheumatic mitral stenosis"
        },
        {
            "@_fa": "true",
            "$": "Stroke"
        },
        {
            "@_fa": "true",
            "$": "Warfarin"
        }
    ]},
    "subject-areas": {"subject-area": [{
        "@_fa": "true",
        "$": "Medicine (all)",
        "@code": "2700",
        "@abbrev": "MEDI"
    }]},
    "authors": {"author": [
        {
            "preferred-name": {
                "ce:given-name": "R.",
                "ce:initials": "R.",
                "ce:surname": "Kaewkanlaya",
                "ce:indexed-name": "Kaewkanlaya R."
            },
            "@seq": "1",
            "ce:initials": "R.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:degrees": "MD.",
            "ce:surname": "Kaewkanlaya",
            "@auid": "57210963784",
            "author-url": "https://api.elsevier.com/content/author/author_id/57210963784",
            "ce:indexed-name": "Kaewkanlaya R."
        },
        {
            "preferred-name": {
                "ce:given-name": "R.",
                "ce:initials": "R.",
                "ce:surname": "Chokesuwattanaskul",
                "ce:indexed-name": "Chokesuwattanaskul R."
            },
            "@seq": "2",
            "ce:initials": "R.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:degrees": "MD.",
            "ce:surname": "Chokesuwattanaskul",
            "@auid": "57202543782",
            "author-url": "https://api.elsevier.com/content/author/author_id/57202543782",
            "ce:indexed-name": "Chokesuwattanaskul R."
        },
        {
            "preferred-name": {
                "ce:given-name": "S.",
                "ce:initials": "S.",
                "ce:surname": "Sb. Songmuang",
                "ce:indexed-name": "Sb. Songmuang S."
            },
            "@seq": "3",
            "ce:initials": "S.",
            "@_fa": "true",
            "affiliation": {
                "@id": "60028190",
                "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"
            },
            "ce:degrees": "MD.",
            "ce:surname": "Sb. Songmuang",
            "@auid": "57210957387",
            "author-url": "https://api.elsevier.com/content/author/author_id/57210957387",
            "ce:indexed-name": "Sb. Songmuang S."
        }
    ]}
}}